Caxton Associates (UK)’s Xeris Biopharma Holdings XERS Stock Holding History

Caxton Associates (UK)’s Portfolio XERS Stock Details XERS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$1.37M	Sell
2025 Q3	$2.29M	Buy
2025 Q2	–	Sell
2025 Q1	$170K	Buy